Connection
Kyle Rove to Neoplasm Staging
This is a "connection" page, showing publications Kyle Rove has written about Neoplasm Staging.
|
|
| |
Connection Strength |
|
 |
|
 |
| |
0.278 |
|
|
|
-
Rove KO, Maroni PD, Cost CR, Fairclough DL, Giannarini G, Harris AK, Schultz KA, Cost NG. Pathologic Risk Factors for Metastatic Disease in Postpubertal Patients With Clinical Stage I Testicular Stromal Tumors. Urology. 2016 11; 97:138-144.
Score: 0.094
-
Rove KO, Maroni PD, Cost CR, Fairclough DL, Giannarini G, Harris AK, Schultz KA, Cost NG. Pathologic Risk Factors in Pediatric and Adolescent Patients With Clinical Stage I Testicular Stromal Tumors. J Pediatr Hematol Oncol. 2015 Nov; 37(8):e441-6.
Score: 0.089
-
Rove KO, Crawford ED. Traditional androgen ablation approaches to advanced prostate cancer: new insights. Can J Urol. 2014 Apr; 21(2 Supp 1):14-21.
Score: 0.079
-
Barqawi AB, Rove KO, Gholizadeh S, O'Donnell CI, Koul H, Crawford ED. The role of 3-dimensional mapping biopsy in decision making for treatment of apparent early stage prostate cancer. J Urol. 2011 Jul; 186(1):80-5.
Score: 0.016